Verinata Health

Verinata Health

Facts & Stats

  • Acquired by Ilumina, February 2013
  • Identifies fetal chromosomal abnormalities through the direct measurement of DNA resulting in a simpler, faster and earlier prenatal test that is easily integrated into existing clinical workflows.
  • Current prenatal screening approaches rely on measurement of surrogate markers that yield highly variable results that are often inconclusive and confusing to both practitioners and patients.
  • Highly experienced management team with key scientific and clinical advisory board members.

iRhythm Technologies

iRhythm Technologies

Facts & Stats

  • Entered into a global partnership with St. Jude Medical to co-market its cardiac rhythm monitors in May 2010.
  • Received four FDA clearances within 14 months.
  • Currently markets the Zio™ Patch (a prescription-only, single-use, continuously recording ECG monitor that can be worn for up to 7 days) and the Zio™ Event Card (a prescription-only, single-use, looping ECG monitor that can be worn for up to 30 days).
  • Experienced Certified Cardiographic Technicians, based at the iRhythm National Clinical Center (iNCC), an Independent Diagnostic Testing Facility, provide monitoring services 24 hours a day, 7 days a week.
  • iRhythm seeks to minimize environmental impact by designing devices 100% of which can be recycled.

 

Crescendo Bioscience

Crescendo Bioscience

Facts & Stats

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects over 1.5MM Americans.
  • Approximately 3,500 rheumatologists treat patients with RA.
  • Vectra DA provides unique insight into inflammatory disease activity at the molecular level.
  • Crescendo was founded by a scientist driven by the profound effect autoimmune disorders have had on his family.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects over 1.5MM Americans.
  • Approximately 3,500 rheumatologists treat patients with RA.
  • Vectra DA provides unique insight into inflammatory disease activity at the molecular level.
  • Crescendo was founded by a scientist driven by the profound effect autoimmune disorders have had on his family.

 

CardioDX

CardioDX

Facts & Stats

  • Maker of the world’s first and only clinically validated blood-based test for obstructive coronary artery disease, one of the single largest diagnostic markets in medicine.
  • CardioDx was recently honored as one of FierceMedicalDevices' Fierce 15 most promising private companies.
  • Named the 2012 Gold Edison Award winner for science and medical.
  • In 2010, the company was honored as a winner of the Wall Street Journal’s prestigious Technology Innovation Awards.
  • Corus® CAD was named one of Time Magazine’s Top Ten Medical Breakthroughs.
  • The PREDICT trial and the company’s scientific work has been published in Annals of Internal Medicine, Circulation Cardiovascular Genetics and the Journal of the American College of Cardiology.
Syndicate content